Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

Pathomechanisms of renal Fabry disease.

pengarang

Øystein Eikrem

Sabine Leh

Einar Svarstad

Camilla Tøndel

Gunnar Houge

diterbitkan dalam: Cell and Tissue Research

tanggal publikasi: 2017-04-12

subyek utama: Fabry disease

Cites articles 55

Date

Judul

Pengarang

2017-05-01

Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients

Sabine Leh, Einar Svarstad, Camilla Tøndel, Rannveig Skrunes
2016-07-22

Biomolecules damage and redox status abnormalities in Fabry patients before and during enzyme replacement therapy

Tatiane Hammerschmidt, Roberto Giugliani
2016-08-01

Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.

Kathy Nicholls, Roser Torra, Dominique P Germain, Derralynn A Hughes, Daniel-G. Bichet, Claudio Feliciani, Roberto Giugliani, Ulla Feldt-Rasmussen
2016-04-15

One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease

Einar Svarstad, Camilla Tøndel
2016-03-09

Targeting Glycosphingolipid Metabolism to Treat Kidney Disease.
2016-10-13

Increased urinary CD80 excretion and podocyturia in Fabry disease

Elsa Zotta, Maria Dolores Sanchez-niño
2015-04-28

DNA damage in Fabry patients: An investigation of oxidative damage and repair

Dinara Jaqueline Moura, Roberto Giugliani
2015-05-14

X-chromosome inactivation in female patients with Fabry disease.

Albert Hagege, Dominique Eladari, Dominique P Germain
2015-08-20

Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide

Sung-Chul Jung
2015-07-01

Real-Time Localization of Parathyroid Adenoma during Parathyroidectomy
2015

Fabry disease
2015-05-08

Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial

Daniel-G. Bichet, Lorne Clarke, Anna Tylki-Szymańska, Beth L. Thurberg
2014-01-08

Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease

Johannes Aerts
2014-12-17

Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.

Einar Svarstad, Camilla Tøndel
2013-05-17

Dysregulated autophagy contributes to podocyte damage in Fabry's disease

Bernhard Schermer, Moin A Saleem, Thomas Benzing, Fabian Braun, Max Christoph Liebau, Roman-Ulrich Müller
2013-11-08

Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease

Thaneas Prabakaran, Rikke Nielsen
2013-03-25

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
2013-12-01

A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis
2013-01-01

Agalsidase benefits renal histology in young patients with Fabry disease

Einar Svarstad, Camilla Tøndel, Bjørn Egil Vikse, Leif Bostad, Gunnar Houge
2013-08-06

Fibrosis: a key feature of Fabry disease with potential therapeutic implications

Maria Dolores Sanchez-niño, Alberto Ortiz, David G Warnock
2012-04-30

Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease

Yi Shi, Cathérine Gebhard, Giovanni G. Camici, Thomas Lüscher, Pedro Brugada
2012-07-26

Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010

Einar Svarstad, Camilla Tøndel, Bjørn Egil Vikse, Leif Bostad
2011-05-04

Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease
2010-08-14

How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?

Wuh-liang Hwu, João Paulo Oliveira, Daniel-G. Bichet, David G Warnock
2010-07-01

Autophagosome maturation is impaired in Fabry disease

Mojgan Djavaheri-Mergny
2010-12-15

Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease

Marie-Claire Gubler, Einar Svarstad, Camilla Tøndel, Leif Bostad
2010-05-26

Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.

Maria Dolores Sanchez-niño, Jose M Valdivielso, Peter Mathieson, Moin A Saleem, Ana B Sanz, Alberto Ortiz
2010-11-22

Fabry disease

Dominique P Germain
2009-01-01

Diagnostic utility of different MRI and MR angiography measures in Fabry disease
2009-10-15

Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).

David G Warnock, Dusan Ferluga, Einar Svarstad, Leif Bostad, Laure-Hélène Noel, Jean-Pierre Grünfeld
2009-04-01

Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease

Anna Tylki-Szymańska, Beth L. Thurberg
2009-02-06

Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse

Artikel - wd:Q48287690

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut